Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
A century-spanning scientific narrative, this piece recounts the discovery and development of GLP-1 by figures like Habener, Mojsov, and Knudsen. Their work culminated in a revolution in medicine, providing highly effective treatments for both diabetes and, notably, obesity.
Discover the fascinating scientific journey from ancient wisdom to modern breakthroughs in understanding and treating obesity, exploring key hormones like leptin and GLP-1.
Dive into the pivotal 2000 research paper that unveiled how scientists at Novo Nordisk, led by Lotte B. Knudsen, designed and developed liraglutide, transforming GLP-1 from a fleeting hormone into a daily medicine.
Journey into the scientific ingenuity that transformed GLP-1 from a daily injection into a powerful once-weekly medication for diabetes and obesity, explaining the precise molecular design behind Semaglutide.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.